Volume | 2,355,874 |
|
|||||
News | (2) | ||||||
Day High | 6.06 | Low High |
|||||
Day Low | 4.3842 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Vigil Neuroscience Inc | VIGL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
4.3842 | 4.3842 | 6.06 | 4.60 | 4.28 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
16,973 | 2,355,874 | US$ 5.05 | US$ 11,908,573 | - | 2.47 - 11.11 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:59:37 | 1 | US$ 5.40 | USD |
Vigil Neuroscience Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
165.04M | 35.88M | - | 0 | -82.64M | -2.30 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Vigil Neuroscience News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VIGL Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 3.18 | 6.06 | 2.47 | 3.59 | 342,815 | 2.07 | 65.09% |
1 Month | 3.34 | 6.06 | 2.47 | 3.55 | 171,836 | 1.91 | 57.19% |
3 Months | 2.77 | 6.06 | 2.47 | 3.32 | 121,478 | 2.48 | 89.53% |
6 Months | 3.31 | 6.06 | 2.47 | 3.31 | 113,229 | 1.94 | 58.61% |
1 Year | 10.30 | 11.11 | 2.47 | 4.74 | 100,242 | -5.05 | -49.03% |
3 Years | 12.00 | 18.27 | 2.18 | 6.98 | 73,039 | -6.75 | -56.25% |
5 Years | 12.00 | 18.27 | 2.18 | 6.98 | 73,039 | -6.75 | -56.25% |
Vigil Neuroscience Description
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. |